Abstract

Background: Most skin illnesses such as psoriasis affect people of all ages and are brought on by radiation, bacteria, or infections. These illnesses continue to spread over time and have a variety of harmful impacts on the skin. When skin disorders are identified and treated in their early stages, cure ratios exceed 95%. Therefore, in order to stop these diseases, it's important to diagnose them early on. Objective: This review includes comprehensive information regarding psoriasis disease such as its epidemiology, causes, various types and current treatments for mild to moderate infection. Methods: This manuscript was carefully selected and assembled for immune-mediated disease as a consequence of the psoriasis disease platform using various origins, such as Google scholar, ScienceDirect, PubMed.A sum of 216 manuscripts underwent collection and analysis, from which 110 were deemed pertinent and included in the present manuscript. Result: In that respect, various treatments to cure psoriasis , which mainly include local treatments are primarily utilized for mild conditions, while photo-therapy is recommended for moderate cases ;which is the most important part of the management of severe psoriasis. Potential factors and triggers associated with psoriasis encompass emotional stress, skin trauma,blood born infection, and particular stimuli.There are several different forms of psoriasis that can be linked by clinical substantiation; these include psoriasis arthritis, crown psoriasis, inverse psoriasis, nail psoriasis, and plaque psoriasis. Conclusion: This review intends to encompass every facet of Psoriasis, detailing its various types and the treatments employed for recovery. This review intends to encompass every facet of Psoriasis, detailing its various types and the treatments employed for recovery.

Keywords

Introduction

An autoimmune skin condition known as psoriasis, which affects 1-3 % of people worldwide, is hyper proliferated.Psoriasis is a prevalent ailment that affects about three percent of the individuals worldwide. It can be painful and make feel uneasy [1]. Psoriasis is regarded as an autoimmune complaint in which inheritable and environmental factors play a significant part. The name of the disease is derived from Greek word ‘psora’ which means ‘itch’ [2]. Globally, psoriasis prevalence has been reported to be approximately 2% [3] This condition causes the skin to continuously form flakes known as psoriasis plaques due to the rapid and excessive growth of epidermal cells, resembling fish scales, and eventually shedding through exfoliation. Argentine-pale pillars arise from  renewal,  amassing of skin due to the fast demolition process.Plaques persistently emerge on the skin of the elbows and knees but can also impact any region, including the scalp and genitals. Talons are constantly forced (psoriasis nail hereditary defect) and can be seen as a quiet finding [4].Unfortunately, dandruff and certain types of arthritis are associated with psoriasis. Additionally, there is strong evidence relating the HIV virus to psoriasis. This review implies compilation of all senses regarding psoriasis, and we also provide an update and the latest evidence for a practical and comprehensive overview of the diagnosis and treatment of psoriasis [5].

Systematic representation of normal skin and skin with psoriasis is given in-figure no1 and 2.

Why bio-logic's for scales and psoriatic arthritis condition?

Psoriasis is a persistent skin condition that impacts both the skin and joints.hospital based emblems encompass erythromatous plaques with Argentine scaling and a habitual intermittent path. Histological, this disease is characterized by hyper proliferation of the cuticle, stretched and conspicuous blood vessels. Psoriasis is now observed as self -immune disease and up to date curatives are available[6].Nevertheless, numerous different treatments are available, but there is invariably a need for current medical attention.A part of us is to enhancement of understanding of the etiology of psoriasis, with succeed “biological”targeted at speci?c way in the etiology of psoriasis, has opened a new way of promising undiscovered treatments [7].

Epidemiology:-

Mainly,epidemiology involves the exploration of distribution (eg.Prevalance and incidence) and determinant (eg.Risk factors) of disease frequency in the population. Psoriasis is seen in any gender and found at any phase of life,most probability found at age 26 years.Near about 1.6% of cases found in the United Kingdom[8]. Shrine psoriasis is ubiquitous,being in more than 82% of occurrences. Gutted psoriasis is near about 12%of occurrence’s  and erythrodermic and pustular psoriasis in diminutive than 3.5% of examples[9]. In people who have skin psoriasis, 10- 55% have psoriasis of the nails (also called psoriatic nail disease). Near about 12- 22% of people who have skin psoriasis and arthritis psoriasis, a precise condition in which people have manifestations of both arthritis and psoriasis of people with psoriatic arthritis, 55- 85% have affected nails, frequently with formation of depression. However, you have a 16- 25% chance of having psoriasis, too. if you have a mother,father or cousins  who have psoriasis, you have a 18%-24% chance of having psoriasis,too. If both your mother and father have psoriasis, your risk is 80%. Males and females are analogously promised to have psoriasis. Psoriasis can occur in individuals all specimens [10].

Origins:-

The origin of psoriasis isn’t completely grasped. It’s ordinarily considered truthful to have an inheritable element. Besides, in psoriasis, components in the immune systems and other pathogenic matter which  typically modulate the augmentation and development of epidermal cells are diminished.[11].Assorted aspects are allowed to infuriate psoriasis. These include worry, extravagant alcohol consumption and smouldering (smoking). Individualities with psoriasis suffer from melancholy and a loss of confidence in our own ability. While similar, quality of life is an important feature in assessing the extremity of the disease .particular drugs, including lithium chloride salt and beta adrenergic blocking agents, have been reported to activate or provoke the disease .

Excessive alcoholism, smoking and chubbiness may complicate psoriasis, making operation of the ambiance delicate. Individualities may come from the increasing effects of the mortal immunosuppression virus or HIV, frequently demonstrate psoriasis [12]. Psoriasis is a without unusual habit  disease. Climatic conditions,weather changes and stress are the major risk for psoriasis disease. “trigger” is not the causing factor for psoriasis as per researchers study. Injury on the skin,mental or emotional stress, low immunity system are some examples of triggers [13]. According to Ayurveda, all summation of factors such as improper digestion,constipation,stress that affect on psoriasis [14]. Medications that can trigger psoriasis are quine category drug, beta-antagonist and alkali metals [15].Medical practitioners observed that psoriasis suddenly seen after a subject takes one of these medications, gets a streptococcal infection. Priors, food can also trigger the disease process. For e.g. citrus fruits, sour foods, sauces, coffee, tea, alcohol and soft drinks [16].

Pathophysiology:-

Psoriasis is a disease that is produced by incorrect signals within the body's immune response. Psoriasis is regarded as happening when the immune system signals the body to overreact and promote development of the skin. Generally, Every 25 to 30 days, the skin's layers grow and fall off from the skin's epidermis [17]. Psoriasis causes skin cells to multiply and migrate to the epidermis's layer between four to eight days the readily apparent scars arise by the outermost layer of cells piling up instead of getting exfoliated. Evidence suggests that psoriasis genes can impact an individual's immune response. This gene is a potential cause of autoimmune diseases like psoriasis and type I diabetes. However, it has been linked to this condition [18] The etiology of psoriasis must be acknowledge in terms of the prominent pathologies occurring in both major factors of the skin the epidermis and the dermis. There are two main key phases that materialized in the formation of the diseases. The primary indication of Psoriasis is the tendency for accelerated cell division and regeneration in the skin. The symptoms are considered to be defects in the epidermis and protein which is produce by hair i.e. keratinocytes [19, 20].   Studies conducted at present indicate that inflammatory responses are initiated by the immune system, starting with the retention of T cells in the skin [21]. Dendrites cells [DCs], macrophages and B cell similar as Langerhans cells, are considered as to relocate from the skin to regional lymph glands, where they correspond with T cells. The antigen which is unknown as T lymphocytes (thymus-lymphocytes), as well as a number of co-stimulatory communications, it stimulates a defense mechanism, leading to thymus lymphocytes cell start its function and the release of immune response of body. Co-stimulatory communication are being started by the way of commerce of fixing motes on the macrophages or antigen- presenting cells, similar as CD58 or lymphocyte function- associated antigen( LFA)- 3 and within the cell sticking of molecule, with their respective receptors cluster of differentiation 2  and LFA- 1 on T cells. These thymocyte cells are released into the systemic blood flow and then back into the epidermal layer. Revitalization of Thymocytes cells in the cutaneous and epidermis and the original goods of growth regulatory hormone similar as endotoxin-induced factor in serum lead to the tenderness, destruction of infected cell by cytotoxic t cells vulnerable signal, and upper layer hyper proliferation seen in persons with psoriasis. The immune- mediated copy of psoriasis has been supported by the inspection that immune squashing medications can clear psoriasis plaques. However, the action of the immune related system is unknown to study, and it has been recently evidenced that an animal model of psoriasis can be triggered in mice lacking Thymocytes cells. This presents a paradox for researchers, as accepted therapies that falls down T-cell counts generally conviction psoriasis to make better [22, 23].

Recent medications available for psoriasis:- Medications or treatments for skin psoriasis encompass local anti inflammatory medicines (corticosteroids), tars, dithranol, vitamin D similarity drugs, acetylic class of retinoid, and 2-Hydroxybenzoic acid drugs [24]. Even though local drugs are enough for many patients, about 22% need summation in systemic drugs. Completely these bear an appreciable prospective for very sober complications, such as the drugs which induced liver damage and neural injury (Methotrexate, cyclosporine), neuroprotective drugs (oral retinoid) etc., which minimize their long-term use [25]. A short time ago an American Academy of study of Dermatology (AAD) concurrence announcement on psoriasis remedial treatments was published [26]. Severe conditions of psoriatic arthritis, which cease to function unprovocative anti-in?ammatory drugs or that existing with arthritic day to day implication or noxious development, are proceeds towards using systemic administration of numerous of the similar complaint make alteration to anti-rheumatic drugs, which successfully make potent in rheumatoid arthritis  remedy, including Rhumatrex, Azulfidine and fungal metabolite i.e. Cyclosporine  [27]Intra-articular admistration with cortisone has been used to treat psoriatic arthritis ?are- ups when more than one joints are imply. Systemic administration of corticosteroids is generally not used as they may gives serious psoriasis skin injury upon breaking off. [28].

Types of psoriasis and their treatment regimens:-

According to the type of conditions:

Plaque psoriasis (psoriasis vulgaris):

Although psoriasis vulgaris is almost all prevalent kind, there are other clinical forms as well. It affects 80-89% of cases with psoriasis. Plaques of this disease usually appear as improved surrounding of redness of skin covered with grayish pale, scaly skin. These affected places are known as plaque [29].

A. Clinical characteristics: 

The all of the common characteristic of plaque psoriasis is the distribution of red, round to oval plaques over the scalp and any muscles that stretch body outer part. Because cutaneous inflammation and epidermal hyper proliferation, the plaques typically show scaling. The prevalence of plaque psoriasis is variable and depends on surrounding factors like as sun light, race, and region. These kinds of flames are lethal. Other than this, psoriasis-related disease-related mortality is incredibly uncommon, and even when it does occur, treatment-related factors are the main cause of death. Adverse effects of photo-therapy and systemic treatments, such as rheumatrex induced hepatic fibrosis e.g. methoxsalen plus UVA induced skin carcinoma with metastases are the first disease-dependent origin of death [30]. The unwholesomeness of this long term and worse condition is further increased by inconvenience, high cost of anti psoriatic treatment regimens, and feelings of shame and self-consciousness about appearance. Patients describe pitting and removal of the plate from the nail surface, noticeable red, itchy areas with increased skin scaling, lesions and desquamation on the scalp and stretch muscle surfaces, and the appearance of new lesions [31].

Causes of Plaque psoriasis:

There are two categories of aggravating variables for plaque psoriasis: systemic and local:

Local factors are as follows:

Sunlight:

Sunlight utmost cases generally consider the sun exist salutary for psoriasis condition. utmost announce a drop in infection inflexibility during the hot weather or ages of increased sun exposure.

Wound:

All types of injury or wound are related to with the formation of plaque psoriasis (e.g. corporeal, synthetically, electrochemical response, invasive procedure, and infectious and other inflammation induced illness) plain uncontrolled scrap can incense or expedite localized psoriasis.

Systemic factors are as follows:

 HIV:

An induced in psoriasis has been found in cases that are pass infection with HIV. The expanse and inflexibility of upper layer of dermis complaint originally found to equal complaint stage. Psoriasis frequently becomes less active in advanced HIV disease.

Hormonal system:

It is more common for women who are pregnant their symptoms to worsen than to get better. On the other hand, the following childbirth phase is when the illness is most prone to escalating up [32].

Diagnosis of Plaque psoriasis:

Psoriasis is often diagnosed only on clinical signs, and additional laboratory testing is never necessary. During the assessment, certain hallmarks of plaque psoriasis are visible, including:

Plaques:

Psoriasis demonstrates as upraised abnormal areas where plaques are seen that differ in size. The stiffen epidermis, makes bigger to dermal circulatory system, and worm into polymorphoneuclear leukocytes and lymphocytes regard for the psoriatic abrasion being expressed furthermore fluently detectable. There are many abrasions which are ranges from many to numerous at particular time. The plaques which are detectable are not in same size to some like coin size and are more and very often reveal on the scalp, limbs and any other body parts along with partiality for the muscles.

Crimson color

The color of psoriatic abrasion is a very individual abundant, all-embracing, and crimson in color. When present on the lower limbs, affected area sometimes carry a blue or little bit pale violet in color.

Scale:

Psoriatic plaques generally have a shrivelled, very small, argentine-pale or sparkling scale; width range of this scale is relatively different not and in particular size. Abolish of the scale show away a smooth, crimson, lustrous surface with little punctuated from where blood is coming out. These punctuated holes ideally represent bleeding from extend dermal capillaries after junking of the intersection supra papillary epithelium [33].

Complications:

Complication Of these disorders is fairly uncustomary. Around 12- 18% of all individuals of plaque psoriasis are companied with psoriatic arthritis. Purities, There are many other symptoms from that one of the most seen is plaque psoriasis, is relatively very different in intensity but shouldn't be ignored. Spiritual insecurity (e.g. elevated situations of anxiety, depression) that related and enhanced by the disorder frequently manifest as an enhanced tendency to scrape. Numerous of the obstacles of shrine psoriasis are related to the treatments for the disease  [34].

Gutted psoriasis: 

Gutted psoriasis show presence with the unexpected coming to view of numerous little (2 – 11 mm) erythematous pustules, frequently gives layer with fine scale). It's seen that more generally in small child and big aged peoples and represents lower than 3.5 % of psoriasis individuals [35]. The lesions of gutted psoriasis are extensively circulated, particularly on the proximal extremities. Abrasion may also be set up on the face. Gutted psoriasis can do in individuals with and without a history of plaque psoriasis [36]. Group A beta-hemolytic streptococcal infection is linked to this condition, which typically occurs 1-4 weeks before skin detection.[37].

Assessment:

The assessment of gutted psoriasis is made by the various additions of history, clinical sign and symptoms of the rash, and strong authentication for antedating infection. Formations of rash are very speedily, generally within a few days or weeks, and observe a streptococcal infection of the throat. It shows that small child and young aged subjects and has a good opportunity of spontaneously clearing  [38].

Medicaments:

Medicaments that involve antibiotics, phototherapy, and topical agents such as mild topically steroid, coal tar, or calcipotriol may be prescribed for the carrier of streptococcal infection. The use of oral medications is infrequent when treating gutted psoriasis. [39].

Pustular psoriasis:-

The growth of sterile pustules on an erythematous skin background, which can be widespread, is the characteristic of generalized pustular psoriasis. Although the exact cause (etiology) of pustular psoriasis is unknown, using certain medications, such as alkali metal group and non-steroidal anti-inflammatory drugs, help to prevent the condition from its developing [40]. Additional factors that contribute comprise infection and an instantaneous discontinuation of systemic cortisones [41]. Both a mild and chronic history and an intense and sudden appearance are possible with generalized pustular psoriasis (von Zumbusch type). The entire body, including the mucosal regions, may become affected by pustules that consolidate [42]. Pustular psoriasis can be either generalized, with extensive patches that appear randomly on any region of the body, or localized, usually to the hands and feet (palmoplantar pustulosis) [43].

Clinical features:-

At first, the skin turns sensitive, dry, and flaming red. In addition, the patient can have chills, a headache, a fast heartbeat, an appetite loss, nausea, and muscle weakness. Within hours, flexures and vaginal regions in particular see the appearance of 3-5 mm pustules packed with non-poisonous pus. They combine to produce lakes of pus after a day, which peel off and dry, leaving a smooth, glazed surface that may eventually sprout new pustule.. A resistant palmoplantar pustular eruption or observable sterile pustules on psoriatic lesions may result from intense neutrophils accumulation [44].

Complications:-

Rarely, severe constitutional symptoms can occur with the development of acute, widespread pustules. This widespread pustular variant of psoriasis can be fatal at times and result in serious morbidity. These generally have pustular blisters, which are red skin surrounding white pustules. Cardiopulmonary collapse during the acute stormy phase can be fatal, so it's critical to start treatment as soon as possible [45].

Treatments:-

Generalized pustular psoriasis can be fatal, that’s why hospitalizations are generally needed. The main work is to help further loss of fluid, stabilize feverishness and recreate electrolyte unevenness.  Generally, other drugs similar as Methotrexate, colchicines, cyclosporine, and hydroxyurea have been used with some success. Phototherapy (ultraviolet radiation), mostly in the summation with PUVA is frequently usefull. This is generally started once the case has been stabilized on citrating [46].

Erythrodermic psoriasis:-

The condition known as Erythrodermic psoriasis can result in severe removing of skin which is significant risk. One of the rarest types of psoriasis, it is found in one-of-the-three cases [47]. From those cases which show evidence of psoriasis who presents with erythrodermic, the erythrodermic is due to the pre existing psoriasis in only 25 of cases. Indeed in subjects with already exist psoriasis ,there is necessary to keep in mind other reasons of psoriasis which is in few quantity[48].

Clinical hallmarks:-

Erythrodermic form of psoriasis is fatal because the too much redness and burning and flaking interchange body’s ability to regulate the skin's intense heat. Psoriasis can gradually spread throughout the skin, causing the skin to appear red with large, very scaly patches. This is rarely the first sign of the disease. This "erythrodermic" syndrome, also known as exfoliating dermatitis, is often correlate with intense heat, hypoalbumunaemia, loss of blood level, and hyperuricemia. There are severe form of psoriasis with itching and inflammation. Erythrodermic psoriasis is associated with wobbly plaque psoriasis, which is recognized by poor disease. In occasional cases, erythrodermic psoriasis may be the patient's first experience of psoriasis [49].

Causes:

A few medicines such as lithium, anti-microbial and interleukin II have been appeared to cause erythrodermic psoriasis. Other causes incorporate diseases, calcium insufficiency, prompt cessation of verbal corticosteroids (prednisone), abuse of topical corticosteroids, and solid coal tar arrangements [50].

Medications:

First-line treatment primarily includes mild topical steroids and moisturizers and wet dressings, cohesive cataracts, and bed rest. Antibacterial agent. Also available: It is very important to restore and maintain fluids in the body. Drug treatment for generalized psoriasis is most effective and is mostly necessary to control extreme cases. [51].

According to where it is found on the body:

Flexural/intertriginous psoriasis:-

Inverse psoriasis (twist psoriasis or skin fold psoriasis) usually occurs in  skin folds such as the armpits, breast skin, around the chin, and between the buttocks. Because it is in skin folds and sensitive areas, it is particularly prone to irritation from friction and sweat. Plaques are fine, have some scale and a bright (non scaly) surface generally attended by subordinate fissuring. The major signs and symptoms manifestation of inverse psoriasis is carefully  terminated erythematous plaques, along with differing degrees of infiltration, which frequently tend to itch and little bit burn [52].

Clinical features:-

Due to the hygroscopic nature of the skin folds, aspects of psoriasis are normally different. There are no argentine scales but looks like very dark and glassy. The deep crimson color and accurate boundaries diagnostic of psoriasis is necessary. There are absences of removal of skin (scales). Scaled could occasionally do still, specifically on the circumcised penis [53].

Treatment:-

A topical treatment gives positive response to flexural psoriasis but frequently re cure. Low potent local steroids with combination of antifungal medicaments will clear flexural psoriasis but in generally reoccur eventually after quitting the treatments. However, it can be given formerly daily and hydrocortisone cream 14 hours after, if it irritates. Systemic agents are infrequently needed.[54].

Palmoplantar pustulosis:-

Unlike most pustular psoriasis, this disease is limited to the palms and soles of the feet [55]. Despite the fact that this form isn't life- hanging as in generalized pustular psoriasis, it's a enervating constrain with high morbidity, as cases can have agonizing pain. Patients with psoriasis on the hands and bases have been  set up to have a worse quality of life than cases with  expansive involvement [56]  Palmoplantar pustulosis generally accounted within 28 and 45 times of life span, and the palmer lesions generally antecede plantar connivance along  plenty months. Especially, the maturities of cases are adult lady, with a adult lady to manly ratio of 8:2 [57].

Scalp psoriasis:-

The scalp is often the site of initial symptoms and is the most common anatomical area affected by psoriasis. Generally infection is spread throughout the scalp with thick plaque or scaled which are not that much thick and appears same as seborrhea dermatitis. Involvement of infection on scalp is constantly lopsided as compare to normal psoriasis [58].

Clinical features:-

Pityriasis amiantacea generally affects only portion of the scalp but may sometimes involve the whole scalp. Pityriasis amiantacea is the bacteria found in scalp psoriasis and where it is presence on scalp their hair loss occurs. Scalp psoriasis is cure if treated effectively. This hair loss is occasionally complicated by the difficulty in combing the hair due to the very fresh complexities. Hair loss could accompanying with scarring and be endless. There are sticky, thick flakes at the roots of the hair. Thick crusted plaques covering whole crown this is the reason of hair loss.

Sign and symptoms:-

Whole crown part is covered by scalp psoriasis. Occasionally small patches are formed which conceivable smuggle or protect with hair. Scalp psoriasis also covers the whole scalp. The gray –pale scale can seen on all over scalp. There are further signs and symptoms are seen in scalp psoriasis:

Dandruff-like flaking:

This is the most ordinarily symptom due to the persist with formation of new skin cells. Gray and dry skin scales formed on the scalp due to cause of scalp psoriasis.

 Itching:

One of the most common symptoms in the scalp psoriasis is itching.

Bleeding:

Scalping of scalp causes bleeding. Scratching ultimately damages the skin, making it prone to developing psoriasis. That's why doctors tell patients, "Don't scratch your scalp."

Short term hair loss:

Frequent scratching of the scalp or forcible removal of dandruff may cause hair loss in patients. After some days hair growth is seen.

Treatments:

For people with scalp psoriasis, the key is to loosen and clear the scales while providing them with as much needed moisture as possible. This is due to the hair making the action of numerous topical products delicate and protecting the crown from UV exposure. Unfortunately, the numerous treatments for scalp psoriasis are inconsistent, ripe  [59].

Nail psoriasis:-

In roughly 55% of all psoriasis cases, changes occur in clinical addition to psoriatic inflammation of the nail matrix and/or a nail bed. The most persistent signs of nail psoriasis are flexor and distal onycholysis. [60].

Psoriatic arthropathy:-

This is inflammation of the joints and connective tissue. Psoriatic arthritis can affect any joint, but most commonly affects the joints of the fingers and toes. This may appear as ring-shaped bumps on the fingers and toes, called dactylitis. Patella joints, buttock and vertebral column can affect by psoriatic arthritis. Around 12-18 of cases who suffer from psoriatic arthritis. Around 15- 25 of subjects who develop psoriasis get a related form of arthritis called „ psoriatic arthritis ? which cause inflammation of the joints [61].

Summary of types of psoriasis is enlisted in table no 1.

Treatments to cure psoriasis:-

There are no permanent treatments are available to cure psoriasis,solitary suppressive medications are available.When prescribed medications are given through this advice, patients with certain psoriasis often decide that taking no medicine is preferable to avoiding stimulating stimulants that worsen their conditions.Medication suggestions might originate from the initial symptoms (discomfort, scratching, flexural psoriasis, the deduction of man-made misdirection owing to physical interaction), cosmetic concerns (noteworthy scars on the palm of your hand, limb, or forehead), or both.  [62].

Topical treatments in psoriasis:-

Corticosteroids:

In the USA, topical corticosteroids are among the most extensively utilized medication to treat psoriasis due to its high degree of case appropriateness, short half-life, and affordability [63]. The multitude of available corticosteroids are different in there efficacy. These results also suggested that treatment once daily due to the lack of skin vexation or clothes staining, the more powerful local corticosteroids provide a persistent, effective effect that acts roughly as quickly as anthralin or coal tar with far greater compliance among patients with topical corticosteroids may be as effective as the more usual twice-daily treatment and may have fewer side effects.Placing ointments in occlusive waxy bags may increase the effectiveness of topical corticosteroids, but increases local costs and  side effects. In adults, use of 35 g or more of  beta-methasone valerate cream 0.026% per day under an occlusive dressing may cause pituitary adrenal suppression [64].

Topical vitamin D3 correspondent : -

 Calcipotriene, calcipotriol are some examples of some synthetic vitamin D-3 analogue,which are both safe and effective to administrate patient. It chunk epidermal proliferation, ameliorate cell maturation and has anti-inflammatory effects. The summation of topical steroids and calcipotriol is strong effective treatments as compare to given as alone. Summation of oral medications along with photo-therapy treatments are also used. Calcium and phosphorous regulation in the body happens with the help of vitamin D, sometimes it will generated by skin when UVA light falls on it [65].

Topical steroids:-

Moderate to mild psoriasis can be effectively treat by the means of topical steroids. While treating moderate or medium spread of psoriasis summation of medications or alone is mostly used. Remedy is generally initiate by the use of potent steroids(clobetasol propionate or betamethason dipropionate) gives formerly or 2 to 3 times in a day. From the category of topical steroids drugs which contains anthralin and salicylic acid derivative may cause itching or redness. Viltigo, hairsutism or skin atrophy like problems may be initiate because of long term and continuous used of topical steroids [66].

Retinoic Acid: -

 From the category of acetylene retinoid derivatives tazarotene is the most potent medication which is prescribe by doctors.Doctors mainly prescribe the dose of gel or cream formulation and which is applied on skin regularly  for 13 weeks. Feasible injurious effects include itching, resistance of drugs, teratogenic reactions, pruritis, redness, wizened, removing of upper layer of skin etc. [67, 68].

Calcineurin antagonist (pimecrolimus and tacrolimus) :-

Management of eczema infection is done with the help of Calcineurin antagonist.Mostly two types of topical antagonist which are enlist in the Calcineurin inhibitors: tacrolimus ointment (0.04 and 0.1%) and pimecrolimus cream (1.0%) [69].

Moisturizers mitigate the dryness that results from the accumulation of skin cells on psoriatic plaques and help calm irritated skin..Coal petroleum, dithranol (anthralin), desoximetasone (Topicort), corticosteroids, vitamin D3 analogues (calcipotriol, for example), and vitamin A frequently appear in ointments and creams. They all contribute to the normalization of skin cell formation and the reduction of inflammation, albeit their exact mechanisms of action may differ. Skin cell growth can be effectively inhibited by activated vitamin D and its equivalent [70].

Coal-tar:

For almost a century, the use of coal tar as a psoriasis treatment has been well-established. Shale pitch, wood pitch (such as pine and juniper), along with raw coal pitch are a few of the tar-based preparations. Tar is useful, but its main drawbacks are that it stains skin, clothing, and furniture, and it is not very attractive. It's commonly utilized as a daily dressing routine or as part of an inpatient regimen [71].

Photo-therapy:- 

1.7.2.1 UVB remedy:-

For lightly to serious psoriasis, UVB therapy remnant one of the major crucial therapeutic approaches. As previously indicated, the application of due to the high rate of clearing and the prolonged length of remission, Goeckerman therapy, when administered daily with occlusive tar, continues to be one of the benchmarks by which other therapies are evaluated. We are currently using the more exact UVB wavelengths that have the greatest therapeutic impact for psoriasis due to its potency and ability to make new skin cells.

UVA remedy:- 

A wavelength 315-400nm namely called ultraviolet region is used in summation with a photo-sensitizing medication. A psoralen substance (generally 8methoxy psoralen i.e.,8MOP) is taken by mouth route followed by exposure to UVA (PUVA therapy = Psoralen UVA). UVA light resistance sunglasses are recommended to use.After positive authorization of the lesions, frequency of prescribe medication is decreases and conservation therapy bring for a different zone. Maturation and development of UVB therapy forms. PUVA treatment not prescribe for children, during infant birth and breastfeeding, and in subjects with liver, kidney or other cardiovascular disease. Other contraindications are the formation of cataracts and infection induced by UVA radiations. Injurious reactions include redness, hotness and  melatonin formation at that affected etc [72].

Systematic treatments:-

Methotrexate:-

Methotrexate, an antacid, is an effectual drug course for some subjects with psoriasis. It is believed that DNA synthesis is suppressed, leading to slow cell growth in tissues that divide rapidly, such as hyper proliferate psoriatic epidermis, gastrointestinal, and germinal epithelium [73].Methotrexate can affect monocyte’s in the skin, blood or lymphoid tissue, causing allergic reactions [74].

Cyclosporine:-

Cyclosporine is the preferred option for treating certain psoriasis in Europe, it is not yet approved for use in the United States. It should be reserved for patients with severe psoriasis that cannot be treated with other medications (topical therapy at higher doses are faster improvement but increases the risk of side effects).The immune system decreasing properties of cyclosporine increase the risk of cancer, although this has not been proven. However ,summation of cyclosporine and photo-therapy is not suggested by doctors. Latest news regarding cyclosporine treatment is that not prescribe for more than 2 year  [75].

Oral retinoid:-

These manufactured compounds have cellular programming akin to that of vitamin A. Multiple retinoid therapies are available to treat keratin formation disorders or serious cases of acne. Acetretin is one of the medications that helps in psoriasis treatment. When combo of medication applied topically or photo-therapy, acetretin is most successful in treating widespread pustular and erythrodermic psoriasis. Retonids is not safe for use,most dangerous effect is birth defect. So women who except baby should never take oral retinoid as a treatment. [76].

Fumaric acid ester:-

 Fumaric acid (also called fumarate) is a mixture of DI-methyl fumarate and mono-ethyl fumarate. Its mechanism of action is to inhibit T-cell activity and switch it from a TH1-type response to a T-helper-type response. Fumarate is mainly prescribe in northern Europe for the medication to subject combine with mild to dangerous psoriasis, and is not approved in the United States.Many randomized controlled trials of fumarates have shown that when Fumadem (with 120 mg DI-methyl fumarate and 87 mg calcium) is first administered as a tablet once daily [77].

phytomedicines or herbal medications :-

 Modern medicine holds great commitment as it is straightforwardly accessible as a good treatment for subjects with skin diseases, especially in tropical and tropical countries including India. Herbal treatment of psoriasis is increasing in popularity and becoming widespread [78].

Silymarin(Milk thistle) :-

Silymarine is known to stave off the development of psoriasis by promoting proper liver function. Treatment of psoriasis does not require antibiotics. However, antibiotics may be used if an infection, such as a Streptococcus bacterial infection, leads to the development of psoriasis, as in some cases of psoriasis. Silymarine has been shown to retard the activation of human T cells that found in psoriasis. However, no particular studies have been conducted on patients with psoriasis. Silymarine containing medications can be purchased in tablet or juice extract form at health food stores [79].

Turmeric:-

Curry Powder made from turmeric is mainly used in its preparation as ground curry powder. Spices has long been used in Chinese medicine. The consumption of turmeric is primarily through the absorption of capsules. In current study turmeric shown that it is help in inflammation,pain,swelling that associated with cancer [79].

Summary of various treatments are enlisted in flow chart 1.

Aloe barbadensis :

Aloe barbidenis a perennial, stem less, aridity-tolerant plant that reserved to used medicinally since ancient times. Belonging to the Liliaceae family, the leaves are gray to green with a clear skin surrounded by a mucilaginous pulp in the middle. Recent studies have shown that the active ingredients in the peel and bark of Aloe Vera leaves. The active substances showed high analgesic, antipyretic, healing and anti-inflammatory properties, so it is reasonable to consider Aloe Vera as an effective treatment for psoriasis [80, 81].

Phytomedicines for External Use in the medication of Psoriasis:-

Andrographis nallamalayanna: 

The herb is used in traditional medicine to cure sterility, leucorrhea, and mouth ulcers [82].

Capsicum annum:

Big perennial shrub with off-white single flowers. Berries make up the fruit, which when ripe might be yellow, or red. A substance found in herbs called capsaicin reduces psoriasis-related discomfort and itching. Dry leaf paste applied externally works well for plaque skin conditions [83, 84, 85].   

Aloe barbadensis:

Appeal in gel form to reduce burning and hotness, which is commonly used herb.

Chamomile:

It is a soothing and anti-inflammatory phytomedicines prescribe as a cream where the infection of psoriasis is spread.

Internal phytomedicines used for Psoriasis  :-

Berberin (barberry, Oregon grape, golden-seal):

Use capsules, teas, or tinctures. Antioxidants, noninflammatory, and by all account prevent injurious development in the bowl.

Dong quai: Taking the capsules early in the illness reduces inflammation.

 Psoralea, bishop's herb or angelica:

 Taken as a capsule, tincture or tea. Contains psoralen; summation with ultraviolet rays, it prevents skin degradation. (The skin becomes more sensitive to ultraviolet rays, increasing exposure to the sun.)

Climatotherapy:-

Climatotherapy is the concept that certain infection can be cured by living in certain climates. The Dead Sea is one of the most beloved places for this type of medications. In Turkey and Croatia (Altermedica), it is recommended that psoriasis patients use medicinal fish in open-air pools to nourish their psoriasis skin. This treatment may temporarily relieve symptoms. You will often need to review the space each month. So far, thermal therapy 2 positive conclusions has been examined  [86].

CONCLUSION: -

The multi-system inflammatory disease, psoriasis has a remarkable impact on quality of life but frequently fails to be diagnosed and treated. In addition to affecting the skin and joints, psoriasis is related to a number of important medical and psychological problems that need to be treated early in order to achieve better as well as long-term effects. Corticosteroids are usually the initial course of action for people with chronic psoriasis or other symptoms. When corticosteroids are not working then alternating photo-therapy or biologics treatment are used widely. This review will undoubtedly open the eyes of psoriasis patients as well as medical professionals, pharmacists, nurses, and others which include the medications of psoriasis and enable them to better comprehend the condition and provide safe and efficient treatment. 

CONSENT FOR PUBLICATION

Not applicable

FUNDING

None

CONFLICT OF INTEREST

The authors declare no conflicts of interest, financial or otherwise

ACKNOWLEDGEMENTS

Declared none

REFERENCES:

1. Alternative Treatment For Psoriasis-A Review. International Journal of Research and Development in Pharmacy and Life Sciences. 2016 May 15; 5(4).
2. Samuel M.L., Donald P.M., Hurley J.H. In Jr. Dermatology,W. B. Philadelphia : Saunders Company, 1986; Vol-1:P. 204.
3. Christophers E. Psoriasis ? epidemiology and clinical spectrum. Clinical and Experimental Dermatology [Internet]. 2001 Jun 1; 26(4):314–20.
4. Camp M., Barker J.N. Psoriasis: Burns D.A., Breathnach S.M., Cox N., Griffiths C.E., Eds. In Rook’s Textbook of Dermatology. 7th ed. Oxford: Blackwell, 2005.35(1):35-69.
5. Walter L.F., Gundula SIn Histopathology of the skin. 3rd Edn., Boston, Massachusetts: Lippincott.1981. P.156-64.
6. Bos JD, De Rie MA. The pathogenesis of psoriasis: immunological facts and speculations. Immunol Today 1999; 20 : 40–46.
7. Kupper TS. Immunologic targets in psoriasis. N Engl J Med 2003;349 : 1987–1990.
8. Nevitt G.J., Hutchinson P.E. Psoriasis in the community; prevalence, severity and patients belief and attitudes towards the disease. Br J Dermatol, 1996; 135:533-537.
9. Biondi Oriente C, Scarpa R, Pucino A, Oriente P. Psoriasis and psoriatic arthritis. Dermatological and rheumatological co-operative clinical report. Acta Dermatol Venereol 1989: 146 (Suppl.): 69–71. 6. National Psoriasis Foundation.
10. Sachappert S.M. Ambulatory care visits to physician offices, hospital outpatient departments and emergency departments: United States, National center for health statistics. Vital health stat 1998;134(13):1-37.
11. Deodhare S.G., General Pathology & Pathology of System, Popular Prakashan, Mumbai, 2nd edition,1553.
12. Robbins, Cotran. Pocket Companion to Pathologic Basis of Diseases, 7th ed., p.620.
13. Joseph T. Dipro, Robert L. Talbert, Gary C. Yee, Barbara G. Wells, Micheal L. Posey, In Pharmacotherapy- A Pathophysiology Approach, 6th edition, 2020;1769-1783.
14. Jain S., Gupta O. P. Dermatitis in Ayurveda with special reference to psoriasis (Kitibha). Aryavaidyan,2005;28(1): 226-34.
15. Kumar, Abbas, Fausto, Robins, Cotran. Pathological Basis of Disease, Published By Savnders, 7th ed., p.1256.
16. Harsh M.Textbook of Pathology. Medical Publisher Ltd. New Delhi, 5th ed., 2006;802-803.
17. Gottlieb SL, Gilleaudeau P, Johnson R, Estes L, Woodworth TG, Gottlieb AB, Krueger JG. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis. Nature Medicine. 1995 May;1(5):442–7.
18. Raychaudhuri S.P., Rein G., Farber E.M. Neuropathogenesis and neuropharmacology of psoriasis. In Int J Dermato, 1995;34:685-693.
19. Yaqoob P. Fatty acids as gatekeepers of immune cell regulation. Trends Immunol, 2003; 24:639-645.
20. Ortonne J.P. Aetiology and pathogenesis of psoriasis.Br J Dermatol, 1996;135(49):1-5.
21. Robert C., Kupper T.S.Inflammatory skin diseases, T cells and immune surveillance. N Engl J Med.1999:341:1817-1828.
22. Pitzalis C., Cauli A., Pipitone N., Cutaneous lymphocyte antigenpositive T lymphocytes preferentially migrate to the skin but not to the joint in psoriatic arthritis. In Arthritis Rheum, 1996; 39:137- 145.
23. Ortonne J.P., Lebwohl M., Em Griffiths C. Alefacept-induced decreases in circulating clood lymphocyte counts correlate with clinical response in patients with chronic plaque psoriasis. In Eur J Dermatol.2003;13(2): 117-23.
24. Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001:  45: 487–498.
25. Lebwohl M, Ali S. Treatment of psoriasis. Part 2. Systemic therapies. J Am Acad Dermatol 2001:  45: 649–661.
26. Callen JP, Krueger GG, Lebwohl M, McBurney IE, Mease P, Menter A, Paller AS, Pariser DM, Weinblatt M, Zimmerman G, AAD consensus statement on psoriasis therapies. J Am Acad Dermatol 2003: 49: 897–899.
27. Heydendael VMR, Spuls PI, Opmeer BC, Reitsma JB,Wouter FM,Goldschmidt MD,Bossuyt PMM, Bos JD, Rie MA.Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003:  349: 658–665.
28. Ruderman EM. Evaluation and management of psoriatic arthritis: the role of biologic therapy. J Am Acad Dermatol 2003:  49 : S125–S132.
29. Henseler T, Christopher E, Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol, 1985,13:450-6.
30. Wardrop P., Waller R., Marais J., Kavangh G. Tonsilitis and chronic plaque psoriasis. In Clin Otolaryngol, 1998;23:67-8.
31. Malerba M., Gisondi P., Radaeli A. Sala R.,Calzavara Pinton P G.,Girolomoni G. Plasma homocysteine and folate levels in patients with chronic plaque psoriasis. Br J Dermatol, 2006;155:1165-1169.
32. Wardrop P., Waller R., Marais J., Kavangh G. Tonsilitis and chronic plaque psoriasis. In Clin Otolaryngol, 1998;23:67-8.\
33. Bandyopadhyay D. Management of Psoriasis: an update. Bulletin on Drug & Health Information, Foundation for Health Action,2006; 13(2).
34. Poulin Y., Pouliot Y., Lamiot E.,Aattouri N.,Gauthier AF. Safety and efficacy of a milk-derived extract in the treatment of plaque psoriasis: an openlabel study.  J Cutan Med Surg, 2005;9:271-275.
35. Menter A, Gottlieb A, Feldman SR, van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JYM, Elmets CA, Korman NJ, et  al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826–50.
36. Martin BA, Chalmers RG, Telfer NR.  HOw great is the risk of further psoriasis following a single episode of acute guttate psoriasis? Arch Dermatol. 1996;132(6):717–8
37. Menter A, Gottlieb A, Feldman SR, van Voorhees AS, Leonardi CL, Gordon KB, Lebwohl M, Koo JYM, Elmets CA, Korman NJ, et  al. Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol. 2008;58(5):826–50.
38. Asumalahti K., Ameen M., Suomela S. Hagforsen E.,Michaelsson G.,Evans J.,et al. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol, 2003;120:627-632.
39. Martin B.A., Chalmers R.J., Telfer N.R. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis?  Arch Dermatol , 1996;132:71778.
40. Schleicher SM. Psoriasis: pathogenesis, assessment, and therapeutic update. Clin Podiatr Med Surg. 2016;33(3):355–66.
41. Griffiths CEM, Barker JNWN.  Pathogenesis and clinical features of psoriasis. The Lancet. 2007; 370(9583):263–71.
42. Varman KM, Namias N, Schulman CI, Pizano LR. Acute generalized pustular psoriasis, von Zumbusch type, treated in the burn unit. A review of clinical features and new therapeutics. Burns. 2014;40(4):e35–9.
43. Martin B.A., Chalmers R.J., Telfer N.R. How great is the risk of further psoriasis following a single episode of acute guttate psoriasis?  Arch Dermatol , 1996;132:717718.
44. Honigsmann H., Gschnait F., Konrad K.,Wolff K. Photochemotherapy for pustular psoriasis (Von Zumbusch).  Br J Dermatol,1997; 97(2):119-26.
45. Zelickson B.D., Pittelkow M.R.,MullerS.A.,JohnsonCM.Polymorphonuclear leukocyte chemotaxis in generalized pustular psoriasis.  Act Derm Venereol, 1987; 67(4):326-330.
46. Umezawa Y., Ozawa A., Kawasima T.,Shimizu H.,Terui T.,Ikeda S.Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity.  Arch Dermatol Res, 2003;295(1):S43-54.
47. Goeckerman WH, O'Leary PA. Erythroderma psoriaticum: a review of twenty-two cases. J Am Med Assoc. 1932;99(25):2102–5.
48. Murphy M, Kerr P, Grant-Kels JM.  The histopathologic spectrum of psoriasis. Clin Dermatol. 2007;25(6):524–8.
49. Creamer D., Allen M.H., Groves R.W., Barker J.N. Circulating vascular permeability factor/vascular endothelial growth factor in erythroderma. Lancet,1996; 348:1101.
50. Sarkar R., Basu S., Sharma R. C. Neonatal and Infantile Erythrodermas. Arch Dermatol,2001; 137(6): 822-823.
51. Tomi N.S., Kränke B., Aberer E.Staphylococcal toxins in patients with psoriasis, atopic dermatitis, and erythroderma, and in healthy control subjects. Journal of the American Academy of Dermatology,2005;3(1):6772.
52. Beylot C. Clinical aspects of psoriasis. Rev Prat 2004; 54: 19–27.
53. Kumar, Abbas, Fausto, Robins, Cotran. Pathological Basis of Disease, Published By Savnders, 7th ed.p.1256
54. Harsh M. Textbook of Pathology. Medical Publisher Ltd. New Delhi, 5th ed.,2006; 802-803.
55. Raposo I, Torres T. Palmoplantar psoriasis and palmoplantar pustulosis: current treatment and future prospects. Am J Clin Dermatol. 2016;17(4):349–58.
56. Pettey AA, Balkrishnan R, Rapp SR, Fleischer AB, Feldman SR.  Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J  Am Acad Dermatol. 2003;49(2):271–5.
57. Sampogna F, Tabolli S, Söderfeldt B, Axtelius B, Aparo U, Abeni D, investigators IDIMPRoVE. Measuring quality of life of patients with different clinical types of psoriasis using the SF-36. Br J Dermatol. 2006;154(5):844–9.
58. Asumalahti K, Ameen, Suomela S, Hagforsen E, Michaëlsson G, Evans J, Munro M, Veal C, Allen M, Leman J, Burden AD, Kirby B, Connolly M, Griffiths CEM,Trembath RC, Kere G, Kere SU, Barker J NWN. Genetic analysis of PSORS1 distinguishes guttate psoriasis and palmoplantar pustulosis. J Invest Dermatol. 2003; 120: 627–632.
59. Bandyopadhyay D.Management of Psoriasis: an update. Bulletin on Drug & Health Information, Foundation for Health Action, 2006;13(2).
60. Salomon J, Szepietowski JC, Proniewicz A. Psoriatic nails: a prospective clinical study. J Cutan Med Surg. 2003; 7: 317–321.
61. Cleland L.G., James M.J.Fish oil and rheumatoid arthritis: antiinflammatory and collateral health benefits. J Rheumatol, 2000; 27:2305-2307.
62. Arnetz BB, Fjellner B, Eneroth P, Kallner A. Stress and psoriasis: psychoendocrine and metabolic reactions in psoriatic patients during standardized stressor exposure. Psychosom Med 1985;47:528-41.
63. Liem WH, McCullough JL, Weinstein GD. Is topical therapy effective for psoriasis: results of survey of U.S. dermatologists. J Invest Dermatol 1992; 98:602. abstract.
64. James VH, Munro DD, Feiwel M. Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate. Lancet 1967;2:1059-61.
65. Garg M., Garg P., Mishra D., Jain S., Agashe H., Jain A.P., et al. Psoriasis: Treatment with Calcipotriol.  Ind J Pharm Sci,2005; 67(3): 283-91.
66. Greaves MW, Weinstein GD. Treatment of psoriasis. In Drug Ther, 1995;332(9):581-7.
67. Njar VC, Gediya L, Purushottamachar P, Chopra P, Vasaitis TS, Khandelwal A, Mehta J, Huynh C, Belosay A, Patel J. Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases. Bioorg Med Chem. 2006; 14(13):4323–40.
68. Marks R. The role of tazarotene in the treatment of psoriasis. Br J Dermatol. 1999; 140 Suppl 54:24–8.
69. Topical treatment of psoriasis Philip M Laws & Helen S Young  . Expert Opin. Pharmacother. 2010l;11(12):1999-2009.
70. Walter J.F., Stoughton R.B., Dequoy P.R. Suppression of epidermal proliferation by ultra violet light, coal tar and anthralin.  Br J Dermatol, 1978;99:89-96.
71. Mease P, Goffe BS. Diagnosis and treatment of psoriatic arthritis. J Am Acad Dermatol. 2005;52(1): 1–19.
72. Mark L. Innovation in the treatment of psoriasis. J American Acad Dermatol,2004; 51(1):40-1.
73. McCullough JL, Weinstein GD. The action of cytotoxic drugs on cell proliferation in psoriasis. In: Wright NA, Camplejohn RS, eds. Psoriasis: cell proliferation. Edinburgh, Scotland: Churchill Livingstone, 1983:347-54.
74. Weinstein GD, Jeffes E, McCullough JL. Cytotoxic and immunologic effects of methotrexate in psoriasis. J Invest Dermatol 1990;95:Suppl:49S-52S.
75. Mihatsch MJ, Wolff K. Consensus conference on cyclosporine A for psoriasis February 1992. Br J Dermatol 1992; 126:621-3.
76. Weinstein GD.,Krueger GG.,Lowe NJ.,DuvicM.,Freidman DJ.,Jejasothy BV. Tazarotene jel, a new retinoid for topical therapy of psoriasis. Vehicle controlled study of safety, efficacy and duration of therapeutic effect.  J American acad Dermatol,1997;37:85-92.
77. Harries MJ, Chalmers RJ, Griffiths CE. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. BrJDermatol.2005; 153(3):549–51.
78. Bradley P. British Herbal Compendium Bournemouth, UK. British Herbal Medicines Association1992.
79. Brown D.J. and Dattner A.M.  Medical journal article on herbs for common skin conditions.  Arch dermatol, 1998;134:1401-04
80. Syed T.A., Ahmad S.A., Holt A.H., Ahmad S.A., Ahmad S.H., Afzal M. Management of psoriasis with Aloe Vera extract in a hydrophilic cream: a placebo controlled, double-blind study.  Trop Med Int Health, 1996;1:505-9.
81. Davis R.H., Parker W.L., Samson R.T., Murdoch D.P. Isolation of a stimulatory system in an aloe extract.  Journal of the American Podiatric Medical Association,1991; 81:473–478.
82. . Sunitha Parlapally Neeraja Cherukupalli, Sudarshana Reddy Bhumireddy, Prabhakar Sripadi, Ravindernath Anisetti, Charu Chandra Giri et al.Chemical profiling and anti-psoriatic activity of methanolic extract of Andrographis nallamalayana J.L.Ellis. Natural Product Research.2015.
83. Joe B, Lokesh BR.Effect of curcumin and capsaicin on arachidonic acid metabolism and lysosomal enzyme secretion by rat peritoneal macrophages. Lipids. 1997;32:1173-1180.
84. Bernstein JE, Parish LC, Rapaport M, Rosenbaum MM, Roenigk HH Jr. Effects of topically applied capsaicin on moderate and severe psoriasis vulgaris. J Am Acad Dermatol.1986;15: 504-507
85. Ellis CN, Berberian B, Sulica VI, Dodd WA, Jarratt MT, Katz HI, Prawer S, Krueger G, Rex. IHJr., Wolf JE. A doubleblind evaluation of topical capsaicin in pruritic psoriasis. J Am Acad. 1993 Sep;29(3):438-42.
86. Hodak E., Gottlieb A.B., Segal., Politi Y.,Maron L.,Sulkes J.Climatotherapy at the Dead Sea is a remittive therapy for psoriasis: combined effects on epidermal and immunologic activation.  J Am Acad Dermatol,2003; 49:451-457.